ArticleJournal of experimental & clinical cancer research : CR2019

Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.

Baochi Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.